Fidelity-backed biopharmaceutical company Kura floated on Nasdaq yesterday and will use proceeds to fund clinical trials.

State-owned debt management firm China Huarong Asset Management raises $2.3bn in its IPO, falling short of its $3bn target.

The classified listings website, spun out of eBay, is seeking a flotation on Chinese stock exchange National Equities Exchange and Quotations.

Vipshop-backed online fashion retailer Showroomprive floated below its range, selling individual shares at $2.25 below target.

The memory product manufacturer had raised more than $85m of debt and equity from backers including Applied Materials and Altera.

The cardiovascular drug developer, which had raised $94m from investors including Sanofi, priced its initial public offering considerably below the range set last week.

Backed by Novo, Johnson & Johnson, Novartis and Pfizer, the immuno-oncology drug developer was previously reported in April 2015 to be seeking a $105m offering.

The Roche-backed oncology treatment developer floated below its range in an IPO in which Pfizer and Bristol-Myers Squibb both acquired shares.

The Samsung-backed flash storage technology provider will float at the middle of the IPO's range, and could potentially raise up to $489m.

The Pfizer, Baxter and Celgene-backed oncology company will raise $43.7m from an initial public offering where the share price was effectively halved in the space of two weeks.